Assert-IQ vs TruPlan
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if you require long-term, continuous cardiac monitoring to diagnose and manage patients with suspected or intermittent heart rhythm disorders. Its advanced arrhythmia detection, remote monitoring capabilities, and proactive alerts are ideal for comprehensive, ongoing patient surveillance where a definitive diagnosis has been elusive.
View Assert-IQ →Choose TruPlan if…
Choose TruPlan if you are performing Left Atrial Appendage Closure (LAAC) procedures and need advanced AI-enabled CT imaging for precise pre-procedural planning and post-procedural follow-up. This tool is specifically designed to optimize LAAC outcomes through detailed anatomical assessment, simulation, and measurement, ensuring accurate device sizing and placement.
View TruPlan →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | TruPlan |
|---|---|---|
| Deployment | Subcutaneously implanted device with mobile app connectivity | Standalone software on desktop/laptop or server within hospital infrastructure with thick-client software on multiple desktops/laptops. It runs locally without an internet connection, though license key activation requires a direct internet connection. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Assert-IQAssert-IQ offers a minimally invasive insertion and remote monitoring capabilities, including a patient activator for symptom logging, which simplifies the user experience for both patients and clinicians by reducing in-person visits. TruPlan, while powerful, is an on-premise imaging software requiring dedicated workstation use and specific expertise for complex anatomical analysis, suggesting a more involved and less 'set-it-and-forget-it' interaction.
Clinical Value
TruPlanBoth tools provide significant clinical value in their respective domains. However, TruPlan's AI-enabled comprehensive pre-procedural planning and simulation for complex Left Atrial Appendage Closure (LAAC) procedures directly impacts the safety and success of an invasive intervention, offering a critical aid in a high-stakes clinical scenario. Assert-IQ focuses on long-term diagnostic and management support for arrhythmias, which is also valuable but less directly tied to immediate procedural outcomes.
Pricing & Value
TruPlanTruPlan explicitly states it 'may be accessible at no additional cost through Boston Scientific representatives' for WATCHMAN procedures, indicating a potential for lower or no direct cost to the end-user institution. Assert-IQ's pricing is 'enterprise' and requires direct contact with Abbott Medical for institutional pricing, offering less transparency and no indication of potential no-cost access.
Enterprise Readiness
Assert-IQBoth tools are FDA cleared and HIPAA compliant, demonstrating regulatory readiness. Assert-IQ's 'hybrid' deployment model and focus on remote monitoring and data export offer greater flexibility and scalability for large health systems, potentially reducing IT overhead compared to TruPlan's 'on-premise (standalone desktop/laptop or server within hospital infrastructure with thick-client)' deployment, which may require more localized IT management.
Innovation
TruPlanWhile Assert-IQ offers innovative long-term, continuous, and remote cardiac monitoring with advanced AI algorithms for arrhythmia detection, TruPlan's application of AI to complex 3D anatomical modeling, automated measurements, and multi-modal procedural simulations (TEE, ICE, Fluoroscopic) for pre-procedural planning of LAAC represents a more advanced and specialized use of AI in surgical intervention and planning.
Support & Docs
TieBoth Abbott Medical (for Assert-IQ) and Circle Cardiovascular Imaging/Boston Scientific (for TruPlan) are established medical technology companies with extensive resources. Web searches indicate both provide comprehensive support, including manuals, guides, and technical assistance for their products. Without specific comparative metrics on response times or documentation quality, it is not possible to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | TruPlan |
|---|---|---|
| Name | Assert-IQ | TruPlan |
| Company | Abbott | Circle Cardiovascular Imaging Inc. |
| Description | The Assert-IQ™ Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | TruPlan by Circle Cardiovascular Imaging is an AI-enabled CT imaging software for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures, offering advanced visualization and measurement tools. |
| Mobile App | yes | TruPlan results can be accessed and reviewed through the cvi42 | Web Viewer, allowing remote viewing of LAA pre-planning cases outside the workstation. |
| Data Export | The myMerlin Mobile App automatically sends heart monitor information to the doctor. | Exports Saved Session to a DICOM file or as a JSON file. It also supports exporting PDF, text, DICOM secondary capture, and DICOM encapsulated PDF for reports. |
| Headquarters | Abbott Park, Illinois, U.S. | Calgary, Alberta, Canada. |
| Founded Year | 1888 | 2007 |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and TruPlan.